|
(S)-Methylarginine
|
|
| Names | |
|---|---|
| Other names
2-Amino-5-[(N’-methylcarbamimidoyl)amino]pentanoic acid; N-Monomethylarginine; omega-N-Methylarginine
|
|
| Identifiers | |
|
17035-90-4 (S) |
|
| 3D model (Jmol) |
Interactive image Interactive image |
| 2262067 (R) | |
| ChEBI |
CHEBI:28229 |
| ChEMBL |
ChEMBL312870 ChEMBL109350 ChEMBL256147 |
| ChemSpider |
4213 2015298 (R) 117259 (S) |
| KEGG |
C03884 |
| MeSH | omega-N-Methylarginine |
| PubChem |
4366 2733510 (R) 132862 (S) |
|
|
|
|
| Properties | |
| C7H16N4O2 | |
| Molar mass | 188.23 g·mol−1 |
| log P | −0.63 |
| Acidity (pKa) | 2.512 |
| Basicity (pKb) | 11.488 |
| Related compounds | |
|
Related alkanoic acids
|
|
|
Related compounds
|
|
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
|
|
|
| Infobox references | |
N-Methylarginine is an inhibitor of nitric oxide synthase. Chemically, it is a methyl derivative of the amino acid arginine. It is used as a biochemical tool in the study of physiological role of nitric oxide.
The inhibiting effect of N-methylarginine on vasodilation is lower in hypertensive patients than in normal subjects, indicating endothelial dysfunction. The inhibiting effect of N-methylarginine on vasodilation declines progressively with age, but has been restored with vitamin C (except in the oldest subjects).